Literature DB >> 17509540

NMDA receptor-mediated extracellular adenosine accumulation is blocked by phosphatase 1/2A inhibitors.

Yin Lu1, Paul A Rosenberg.   

Abstract

We have previously demonstrated that NMDA receptor-mediated extracellular adenosine accumulation in neuronal cultures is receptor-mediated and requires calcium influx. Because protein kinase C (PKC) is a calcium-dependent enzyme, we hypothesized that activation of PKC might be involved in NMDA-mediated adenosine accumulation. PKC inhibitors, however, did not block NMDA-evoked adenosine accumulation, but rather, stimulated basal adenosine accumulation. These data suggested the possibility that NMDA receptor-mediated adenosine accumulation involves net dephosphorylation rather than phosphorylation of one or more substrates. Thus, inhibition of kinases would be expected to increase adenosine accumulation and inhibition of phosphatases would be expected to block adenosine accumulation. To test this hypothesis, we used the phosphatase 1/2A inhibitors calyculin A and okadaic acid. Both inhibitors significantly reduced NMDA-evoked adenosine accumulation. In contrast phosphatase 2B inhibitors did not block NMDA-evoked adenosine accumulation. These data suggest that NMDA-evoked adenosine accumulation is mediated by activation of phosphatase 1/2A. We have established previously that NMDA-mediated adenosine accumulation is associated with adenosine kinase inhibition. However, adenosine kinase is not a direct substrate for phosphatase 1/2A because inhibition of phosphatase 1/2A did not abolish NMDA-evoked adenosine kinase inhibition. Okadaic acid also had no effect on NO donor-evoked adenosine accumulation, which previously has been shown to be associated with adenosine kinase inhibition. Dephosphorylation of one or more proteins other than adenosine kinase as a consequence of NMDA receptor activation might play an important role in extracellular adenosine regulation, with important consequences for the regulation of excitatory synaptic transmission, plasticity, epileptogenesis, and excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509540      PMCID: PMC3626428          DOI: 10.1016/j.brainres.2007.04.057

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  71 in total

Review 1.  Brain protein serine/threonine phosphatases.

Authors:  N E Price; M C Mumby
Journal:  Curr Opin Neurobiol       Date:  1999-06       Impact factor: 6.627

2.  Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease.

Authors:  Ken Ikeda; Masako Kurokawa; Shiro Aoyama; Yoshihisa Kuwana
Journal:  J Neurochem       Date:  2002-01       Impact factor: 5.372

3.  An NMDA receptor signaling complex with protein phosphatase 2A.

Authors:  S F Chan; N J Sucher
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

Review 4.  Enzymes involved in purine metabolism--a review of histochemical localization and functional implications.

Authors:  Y Moriwaki; T Yamamoto; K Higashino
Journal:  Histol Histopathol       Date:  1999-10       Impact factor: 2.303

5.  Inhibition of adenosine kinase during oxygen-glucose deprivation in rat cortical neuronal cultures.

Authors:  J J Lynch; K M Alexander; M F Jarvis; E A Kowaluk
Journal:  Neurosci Lett       Date:  1998-08-21       Impact factor: 3.046

6.  Expression of CD 73 (ecto-5'-nucleotidase) in 165 glioblastomas by immunohistochemistry and electronmicroscopic histochemistry.

Authors:  H C Ludwig; S Rausch; K Schallock; E Markakis
Journal:  Anticancer Res       Date:  1999 May-Jun       Impact factor: 2.480

7.  Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart.

Authors:  G J Harrison; R J Willis; J P Headrick
Journal:  Cardiovasc Res       Date:  1998-10       Impact factor: 10.787

8.  A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor.

Authors:  G L Snyder; A A Fienberg; R L Huganir; P Greengard
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

9.  Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A.

Authors:  Akinori Nishi; James A Bibb; Seiichiro Matsuyama; Miho Hamada; Hideho Higashi; Angus C Nairn; Paul Greengard
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

10.  Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist.

Authors:  D K Von Lubitz; R C Lin; N Bischofberger; M Beenhakker; M Boyd; R Lipartowska; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1999-03-26       Impact factor: 4.432

View more
  3 in total

Review 1.  Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.

Authors:  Pradip K Kamat; Anuradha Kalani; Shivika Rai; Supriya Swarnkar; Santoshkumar Tota; Chandishwar Nath; Neetu Tyagi
Journal:  Mol Neurobiol       Date:  2014-12-17       Impact factor: 5.590

2.  Hydrogen Sulfide Epigenetically Attenuates Homocysteine-Induced Mitochondrial Toxicity Mediated Through NMDA Receptor in Mouse Brain Endothelial (bEnd3) Cells.

Authors:  Pradip K Kamat; Anuradha Kalani; Suresh C Tyagi; Neetu Tyagi
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

3.  Modified Huang-Lian-Jie-Du Decoction Ameliorates Aβ Synaptotoxicity in a Murine Model of Alzheimer's Disease.

Authors:  Yan Liu; Ting Du; Wenlong Zhang; Weiye Lu; Zhichao Peng; Shuqiong Huang; Xiangdong Sun; Xiaoqin Zhu; Chaojun Chen; Linchao Qian; Lei Wen; Pingyi Xu; Yunlong Zhang
Journal:  Oxid Med Cell Longev       Date:  2019-11-03       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.